CHINA BRIEF | Tencent rolls out AI platform iDrug to shorten research time for new drugs

Written by Song Jingli Published on 

More than 10 projects, including potential cures for COVID-19, are currently running on iDrug.

Chinese tech giant Tencent has launched iDrug, an AI-driven software platform, to aid new medicine development, according to a press release issued by the company on Thursday.

Developed by Tencent’s AI lab, iDrug was designed to speed up the entire process of pre-clinical drug discovery with its machine learning capabilities, according to the release. The platform is made up of five models for protein structure prediction, virtual screening, generative chemistry, ADMET (absorption, distribution, metabolism, excretion and toxicity/pharmacokinetic) prediction, and synthetic route planning. The virtual screening and ADMET prediction models are already online, open to all pharmaceutical companies and research institutes for free, with the remaining three models to come online soon.

More than 10 projects—including potential cures for COVID-19 from several pharmaceutical companies—are now running on iDrug, said Tencent in the press release.

Read this: AI to boost doctors’ efficiency with imaging diagnostics: Inside China’s Startups

This article is part of KrASIA’s “China Brief” section, where KrASIA’s reporters will provide quick daily updates about the tech ecosystem in China.


You might like these

  • Insights

    Israeli startup Albo takes on carbon monitoring with AI, satellite imaging



    17 Jan 2021    01:35 AM

KrASIA InsightsKrASIA Insights

  • By catering to the global hunger for EVs and its domestic economic growth, Indonesia risks destroying its own environment.


    Indonesia’s EV battery aspirations unearth mining waste problems

    By Ursula Florene

    15 Jan 202101:05 AM

Most PopularMost Popular

See All